About TACT Genomics
Genomics innovation is a critical solution to conquer cancer & other diseases.
Develop innovative scientific tools assisting in definitive cancer detection & fostering customized treatments of complex diseases.
TACT Genomics is a biotech & pre-clinical startup, with expertise in significant basic science and clinical research that facilitates precision diagnosis and customized treatment to patients with cancer. Our expertise includes cell and molecular biology, gene expression, in vitro disease models, preclinical & clinical development, molecular marker identification, and development of quantitative molecular assays, et. al..